T cell knockout mice have diminished alveolar bone loss after oral infection with Porphyromonas gingivalis

FEMS Immunology and Medical Microbiology

Volumn 34, Issue 1, 2002, Pages 45-50

  Baker, Pamela J ^a   Howe, Lisa ^a   Garneau, Jessica ^a   Roopenian, Derry C ^b  

^a BATES COLLEGE   (United States)

^b JACKSON LABORATORY   (United States)

Author keywords

Alveolar bone loss; Periodontal disease; Porphyromonas gingivalis; Tcra knockout mouse

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; T LYMPHOCYTE RECEPTOR;

ALPHA CHAIN; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE DELETION; IMMUNOCOMPETENCE; KNOCKOUT MOUSE; LYMPHOCYTE COUNT; MOUSE; MOUTH INFECTION; NONHUMAN; OSTEOLYSIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; STRAIN DIFFERENCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ALVEOLAR BONE LOSS; ANIMALS; BACTEROIDACEAE INFECTIONS; DISEASE MODELS, ANIMAL; FEMALE; GENES, T-CELL RECEPTOR ALPHA; IMMUNOCOMPETENCE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS; T-LYMPHOCYTES;

EID: 0037031603     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(02)00348-6     Document Type: Article

References (35)

1. Williams R.C. Periodontal disease. New Engl. J. Med. 322:1990;373-382.
2. Armitage G.C. Development of a classification system for periodontal diseases and conditions. Ann. Periodontol. 4:1999;1-6.
3. Brown L.J., Loë H. Prevalence, extent, severity and progression of periodontal disease. Periodontology. 2:1993;57-71.
4. Pilot T., Miyazaki H. Periodontal conditions in Europe. J. Clin. Periodontol. 18:1991;353-357.
5. Socransky S.S., Haffajee A.D. The bacterial etiology of destructive periodontal disease: Current concepts. J. Periodontol. 63:1992;322-331.
6. Tanner A.C.R., Socransky S.S., Goodson J.M. Microbiota of periodontal pockets losing crestal alveolar bone. J. Periodont. Res. 19:1984;279-291.
7. van Winkelhoff, A.J., van Steenbergen, T.J.M. and de Graaff, J. (1993) Occurrence and association with disease. In: Biology of the Species Porphyromonas gingivalis (Shah, H.N., Mayrand, D. and Genco, R.J., Eds.), pp. 33-42. CRC Press, Boca Raton, FL.
8. Mahanonda D., Seymour G.J., Halliday J.W., Powell L.W., Good M.F. Limit dilution analysis of peripheral blood T-lymphocytes specific to periodontopathic bacteria. Clin. Exp. Immunol. 75:1989;245-251.
9. Ogawa T., Kono Y., McGhee M.L., McGhee J.R., Roberts J.E., Hamada S., Kiyono H. Porphyromonas gingivalis-specific serum IgG and IgA antibodies originate from immunoglobulin-secreting cells in inflamed gingiva. Clin. Exp. Immunol. 83:1991;237-244.
10. Cutler C.W., Jotwani R., Palucka K.A., Davoust J., Bell D., Banchereau J. Evidence and a novel hypothesis for the role of dendritic cells and Porphyromonas gingivalis in adult periodontitis. J. Periodont. Res. 34:1999;406-412.
11. Nakajima T., Yamakazi K., Cullinan M., Gemmell E., Seymour G. T-cell antigen specificity in humans following stimulation with Porphyromonas gingivalis. Arch. Oral Biol. 44:1999;1045-1053.
12. Baker P.J., Evans R.T., Roopenian D.C. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch. Oral Biol. 39:1994;1035-1040.
13. + T cells and the proinflammatory cytokines interferon gamma and interleukin-6 contribute to alveolar bone loss in mice. Infect. Immun. 67:1999;2804-2809.
14. Teng Y.-T.A., Nguyen H., Gao X., Kong Y.-Y., Gorczynski R.M., Singh B., Ellen R.P., Penninger J.M. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J. Clin. Invest. 106:2000;R59-R67.
15. Kong Y.-Y., Boyle W.J., Penninger J.M. Osteoprotegerin ligand: a regulator of immune responses and bone physiology. Immunol. Today. 21:2000;495-502.
16. 2 microglobulin-deficient mice show abnormal Ig homeostasis and are protected from lupus-like autoimmunity. J. Immunol. 159:1997;4780-4792.
17. Eichelberger M., McMickle A., Blackman M., Mombaerts P., Tonegawa S., Doherty P.C. Functional analysis of the TCR alpha- beta+ cells that accumulate in the pneumonic lung of influenza virus-infected TCR-alpha-/- mice. J. Immunol. 154:1995;1569-1576.
18. Baker P.J., Garneau J., Howe L., Roopenian D.C. T cell contributions to alveolar bone loss in response to oral infection with Porphyromonas gingivalis. Acta Odontol. Scand. 59:2001;222-225.
19. Klausen B., Evans R.T., Sfintescu C. Two complementary methods of assessing periodontal bone level in rats. Scand. J. Dent. Res. 97:1989;494-499.
20. Baker P.J., Dixon M., Roopenian D.C. Genetic control of susceptibility to alveolar bone loss in mice. Infect. Immun. 68:2000;5864-5868.
21. Baker P.J. The role of immune responses in bone loss during periodontal disease. Microb. Infect. 2:2000;1181-1192.
22. Lam J., Takeshita S., Barker J.E., Kanagawa O., Ross F.P., Teitelbaum S.L. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106:2000;1481-1488.
23. Bertolini D.R., Nedwin T., Bringman T., Smith D., Mundy G.R. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature. 319:1985;516-518.
24. Mann G.N., Jacobs T.W., Buchinsky F.J., Armstrong E.C., Li M., Ke H.Z., Ma Y.F., Jee W.S.S., Epstein S. Interferon-γ causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia. Endocrinology. 135:1994;1077-1083.
25. Aoyagi T., Sugawara-Aoyagi M., Yamakazi K., Hara K. Interleukin 4 (IL-4) and IL-6-producing memory T cells in peripheral blood and gingival tissues in periodontitis patients with high serum antibody titers to Porphyromonas gingivalis. Oral Microbiol. Immunol. 10:1995;304-310.
26. Ogawa T., Uchida H. A peptide, ALTTE, within the fimbrial subunit from Porphyromonas gingivalis, induces production of interleukin 6, gene expression and protein phosphorylation in human peripheral blood mononuclear cells. FEMS Immunol. Med. Microbiol. 11:1995;197-206.
27. Houri-Haddad Y., Soskolne W.A., Halabi A., Barak V., Shapira L. Repeat bacterial challenge in a subcutaneous chamber model results in augmented tumor necrosis factor-alpha and interferon-gamma response, and suppression of interleukin-10. Immunology. 99:2000;215-220.
28. Hofbauer L.C., Heufelder A.E. Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis. Eur. J. Endocrinol. 139:1998;152-154.
29. Roodman G.D. Cell biology of the osteoclast. Exp. Hematol. 27:1999;1229-1241.
30. Horwood N.J., Kartsogiannis V., Quinn J.M.W., Romas E., Martin T.J., Gillespie M.T. Activated T lymphocytes support osteoclast formation in vitro. Biochem. Biophys. Res. Commun. 265:1999;144-150.
31. Kong Y.-Y., Feige U., Sarosi I., Bolon B., Tafuri A., Morony S., Capparelli C., Li J., Elliott R., McCabe S., Wong T., Campagnuolo G., Moran E., Bogoch E.R., Van G., Nguyen L.T., Ohashi P.S., Lacey D.L., Fish E., Boyle W.J., Penninger J.M. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 402:1999;304-308.
32. Josien R., Wong B.R., Li H.-L., Steinman R.M., Choi Y. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J. Immunol. 162:1999;2562-2568.
33. Wong B., Josien R., Choi Y. TRANCE is a TNF family member that regulates dendritic cell and osteoclast function. J. Leukoc. Biol. 65:1999;715-724.
34. Ukai T., Hara Y., Kato I. Effects of T cell adoptive transfer into nude mice on alveolar bone resorption induced by endotoxin. J. Periodont. Res. 31:1996;414-422.
35. Kong Y.-Y., Yoshida H., Sarosi I., Tan H.-L., Timms E., Capparelli C., Morony S., Oliveira-dos Santos A.J., Van G., Itie A., Khoo W., Wakeham A., Dunstan C.R., Lacey D.L., Mak T.W., Boyle W.J., Penninger J.M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397:1999;315-323.